scispace - formally typeset
Open AccessJournal ArticleDOI

Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the association of rheumatologists of Russia

Reads0
Chats0
TLDR
The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.
Abstract
In mid-2021, the SARS-CoV-2 (Severe Acute Respiratory coronavirus 2) infection, which caused the coronavirus disease (COVID-19) pandemic, affected more than 157 million people in all regions of the world and led to more than 3.2 million deaths. It is assumed that elderly age, uncontrolled inflammation, anti-inflammatory therapy, comorbid pathology, genetic and other factors can potentially lead to an increase in “sensitivity” to viral and bacterial infections, including SARS-CoV-2. The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Деплеция в-клеток при иммуновоспалительных ревматических заболеваниях и коронавирусная болезнь 2019 (covid-19)

TL;DR: According to the recommendations of the Association of Rheumatologists of Russia, a more rigorous assessment of indications for induction and maintenance therapy of RTX therapy and harmonization of the timing of drug administration and vaccination is required.
Journal ArticleDOI

Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues

TL;DR: The frequency of exacerbation of RD after vaccination against COVID-19 seems to be quite low (5–7%) and has no significant associations with a specific vaccine or anti-rheumatic therapy, and unambiguous interpretation is difficult.
Journal ArticleDOI

Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology

TL;DR: The current achievements, trends and recommendations regarding the use of JAK inhibitors in the treatment of IMIDs and also in the hyper-response phase of COVID-19 are reviewed.
Journal ArticleDOI

Rheumatoid arthritis and post-COVID-19 syndrome

TL;DR: It is thought that SARS-CoV-2 infection may be a trigger factor for new rheumatic musculoskeletal diseases, including rheumatoid arthritis or COVID-19 can unmask previously undetected RA, and arthritis in the post covid period may induce problems in differential diagnosis of rhematic diseases.
Journal ArticleDOI

Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)

TL;DR: Preliminary data suggest that vaccination against COVID-19 in patients with IRD appears to be quite safe, and further studies are needed to investigate the safety, immunogenicity, and clinical efficacy of CO VID-19 immunization in rheumatic patients.
References
More filters
Journal ArticleDOI

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

TL;DR: There is evidence that TNF-α inhibitors increase the serious infection risk up to 2-fold in a dose-dependent manner and glucocorticoids have been used as potent immunosuppressive drugs in RA, which has the potential to outweigh their risk when higher GC doses can be tapered down.
Journal ArticleDOI

Updated assessment of the prevalence, spectrum and case definition of autoimmune disease.

TL;DR: A comprehensive up-to-date list of the autoimmune diseases, and a tentative proposal for criteria for assigning autoimmune pathogenesis to a particular disease, are led to.
Journal ArticleDOI

Willingness to get the COVID-19 vaccine with and without emergency use authorization.

TL;DR: Concerns about rushed vaccine development appear to reduce vaccine uptake intent, as well as willingness to get the vaccine under EUA, and COVID-19 vaccine-related messages should address concerns about the vaccine and its development and reinforce benefits of the vaccine.
Related Papers (5)